Skip to main content
. 2014 Apr;6(4):348–355. doi: 10.3978/j.issn.2072-1439.2013.11.07

Figure 4.

Figure 4

Schema for prospective phase I/II study of hypofractionated PBT, with concurrent chemotherapy, for stage II-III non-small cell lung cancer. This dose-escalation study will enroll 28 patients in the phase I component and 61 in the phase II component. Abbreviations: PCG, Proton Cooperative Group; fx, fractions.